Athira Pharma, Inc. (ATHA) Tops Q1 EPS by 11c
Tweet
Share
E-mailGet Alerts ATHA Hot Sheet
Join SI Premium – FREE
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.69), $0.11 better than the analyst estimate of ($0.80).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Top Wealth Group expects net profit to double in fiscal 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
